[1]
Wongsurawat, N. et al. 2022. Low versus high 131I therapeutic effectiveness for differentiated thyroid cancer with intermediate risk of recurrence. Asia-Pacific Journal of Science and Technology. 27, 04 (May 2022), APST–27. DOI:https://doi.org/10.14456/apst.2022.56.